Identification of two novel RHO mutations in Chinese retinitis pigmentosa patients

色素性视网膜炎 遗传学 鉴定(生物学) 生物 眼科 医学 视网膜 植物
作者
Juan Wang,Ding Xu,Tong Zhu,Yue Zhou,Xin Chen,Fang Wang,Jieping Zhang,Haibin Tian,Furong Gao,Jingfa Zhang,Caixia Jin,Jingying Xu,Lixia Lü,Qin Liu,Guo‐Tong Xu
出处
期刊:Experimental Eye Research [Elsevier BV]
卷期号:188: 107726-107726 被引量:8
标识
DOI:10.1016/j.exer.2019.107726
摘要

Retinitis pigmentosa (RP) is a group of genetically heterogeneous retinal diseases with more than 80 identified causative genes to date. Mutations in the RHO (rhodopsin, OMIM, 180380) are the most common cause of autosomal dominant RP (adRP) worldwide. RHO is also one of the few RP genes that can cause autosomal recessive RP (arRP). To explore the frequency of RP mutations in Chinese populations, panel-based NGS (next-generation sequencing) screening and Sanger sequencing validation were performed for RP patients from 72 unrelated Chinese families. Here we reported the identified mutations only in the RHO gene. Our results showed that 4 mutations in RHO were detected in 5 (6.94%) of the 72 RP families, including two known missense mutations, c.158C > G (p.P53R) and c.551A > C (p.Q184P), and two novel mutations, c.34delC (p.P12NA) and c.82C > T (p.Q28X). The c.34delC (p.P12NA) mutation was detected in heterozygous state in one patient with intermediate RP phenotype. The c.82C > T (p.Q28X) mutation was found in a homozygous state in one proband with advanced RP phenotype at the age of 32. Clinical examination of the heterozygous carriers of c.82C > T (p.Q28X) in that family showed that the father at the age of 60s experienced no symptoms of RP and normal fundus examinations but displayed reduced electroretinography (ERG) and abnormal visual field. The sister and brother at the age of 30s showed no typical aspects of RP phenotypes. Our results not only expand the mutation spectrum of the RHO gene, but also suggest that the 2 null mutations might play minor dominant effects, leading to less severe and slower retinal degeneration in heterozygous state and more severe phenotype in homozygous state.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
HMS完成签到,获得积分10
刚刚
Jasper应助时节守采纳,获得10
1秒前
man完成签到,获得积分10
1秒前
1秒前
封似狮完成签到,获得积分10
1秒前
1秒前
1秒前
2秒前
梦明完成签到 ,获得积分10
3秒前
3秒前
Cmiudz完成签到,获得积分10
4秒前
高小高完成签到,获得积分10
4秒前
4秒前
stella完成签到,获得积分10
4秒前
莫天枫完成签到,获得积分10
4秒前
饺子发布了新的文献求助10
5秒前
Jacob完成签到,获得积分10
5秒前
多宝完成签到,获得积分10
6秒前
远方完成签到,获得积分10
6秒前
大强发布了新的文献求助10
6秒前
ZZZ发布了新的文献求助10
6秒前
小孙完成签到 ,获得积分10
7秒前
拼搏的宇完成签到,获得积分10
7秒前
CYJ完成签到,获得积分10
7秒前
7秒前
守望者发布了新的文献求助10
7秒前
光电效应完成签到,获得积分10
7秒前
123发布了新的文献求助10
8秒前
CodeCraft应助痴情的夏旋采纳,获得10
8秒前
8秒前
8秒前
尧九完成签到,获得积分10
8秒前
勤劳元瑶完成签到,获得积分10
8秒前
8秒前
ZT完成签到,获得积分10
8秒前
像只猫完成签到,获得积分10
8秒前
10秒前
龙虾发票完成签到,获得积分0
10秒前
无花果应助GDD采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6951786
求助须知:如何正确求助?哪些是违规求助? 8636020
关于积分的说明 18311955
捐赠科研通 6394399
什么是DOI,文献DOI怎么找? 3082215
关于科研通互助平台的介绍 2127533
邀请新用户注册赠送积分活动 2059101